financetom
Business
financetom
/
Business
/
BBVA Research Sees Two 25bps Rate Cuts At Peru's Central Bank by End Q2 2025 After Last's Week Hold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BBVA Research Sees Two 25bps Rate Cuts At Peru's Central Bank by End Q2 2025 After Last's Week Hold
Dec 16, 2024 6:24 AM

08:49 AM EST, 12/16/2024 (MT Newswires) -- The Board of Peru's central bank (BCRP) last week kept the reference interest rate at 5.00%, noted BBA Research.

BCRP expected both headline and core inflation to remain within the target range over the projection horizon, pointed out BBVA Research. It also states that economic activity was now around its potential level.

BBVA Research stated it anticipates two 25bp cuts to the reference rate before the end of Q2 2025, aligning it with the neutral rate at 4.5% in nominal terms. The timing of these cuts will largely depend on developments in financial markets.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
United Therapeutics Insider Sold Shares Worth $3,784,419, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $3,784,419, According to a Recent SEC Filing
Nov 25, 2025
04:51 PM EST, 11/25/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on November 24, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,784,419. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled indirectly. SEC...
Autodesk Reports Better-Than-Expected Q3 Results, Shares Rise
Autodesk Reports Better-Than-Expected Q3 Results, Shares Rise
Nov 25, 2025
Autodesk Inc ( ADSK ) reported third-quarter financial results for fiscal 2026 Tuesday after the bell. Here’s a rundown of the report. ADSK is charging ahead with explosive momentum. Get the details here. Q3 Highlights: Autodesk ( ADSK ) said third-quarter revenue increased 18% year-over-year to $1.85 billion, beating analyst estimates of $1.81 billion. The software company reported third-quarter adjusted earnings...
Noah Q3 Adjusted Earnings Rise, Revenue Falls
Noah Q3 Adjusted Earnings Rise, Revenue Falls
Nov 25, 2025
04:49 PM EST, 11/25/2025 (MT Newswires) -- Noah Holdings ( NOAH ) reported Q3 adjusted earnings late Tuesday of 3.26 renminbi ($0.46) per diluted American depositary share, up from 2.14 renminbi a year earlier. Revenue in the three months ended Sept. 30 fell to 632.9 million renminbi from 683.7 million renminbi a year earlier. ...
US FDA approves Otsuka's drug for a type of kidney disease
US FDA approves Otsuka's drug for a type of kidney disease
Nov 25, 2025
Nov 25 (Reuters) - The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator's website showed on Tuesday. The drug, branded as Voyxact, was approved to reduce proteinuria in patients with primary immunoglobulin A nephropathy, which causes inflammation in the kidneys and can eventually lead to the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved